Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Systematic Search Into The Role Of IGHV Gene Replacement In Shaping The Immunoglobulin Repertoire Of Chronic Lymphocytic Leukemia

Sophia Yancopoulos, PhD, Xiao-Jie Yan, MD PhD, Andreas Agathangelidis, Wentian Li, Ph.D., Chrysoula Belessi, Paolo Ghia, MD, PhD, Richard Rosenquist, MD, PhD, Frederic Davi, MD, PhD, David Graham Oscier, MD, Sarka Pospisilova, Panagiotis Panagiotidis, MD, Lin Huang, PhD, Zhixin Zhang, PhD, Steven L. Allen, MD, Jaqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Kostas Stamatopoulos, MD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 4129.

https://doi.org/10.1182/blood.V122.21.4129.4129

Published: 2013

Journal Articles

Apparent Involvement Of The Interferon, RNA Processing, and Wnt Signaling Pathways In Monoclonal B Lymphocytosis

Xiao-Jie Yan, MD PhD, Claudia Fazi, PhD, Scarfo Lydia, MD, Wentian Li, Ph.D., Jonathan E. Kolitz, MD, Jacqueline C. Barrientos, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Paolo Ghia, MD, PhD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 4157.

https://doi.org/10.1182/blood.V122.21.4157.4157

Published: 2013

Journal Articles

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Xiao J. Yan, MD, PhD, Wentian Li, Ph.D., Sophia Yancopoulos, PhD, Igor Dozmorov, PhD, Carlo Calissano, MD, Sonia Marsilio, PhD, Rajendra N Damle, PhD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Jacqueline C. Barrientos, MD, Kanti R. Rai, M.D., Nicholas Chiorazzi, MD

Blood (2012) 120 (21): 317.

https://doi.org/10.1182/blood.V120.21.317.317

Published: 2012

Journal Articles

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 1774.

https://doi.org/10.1182/blood.V118.21.1774.1774

Published: 2011

Journal Articles

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

Xiao J. Yan, MD, PhD, Daniel Kalenscher, Erin Boyle, Sophia Yancopoulos, PhD, Rajendra N Damle, PhD, Aarti Damle, Houman Khalili, Annette Lee, PhD, Wentian Li, Ph.D., Igor Dozmorov, MD, PhD, Matthew Kaufman, M.D., Peter Gregersen, MD, Steven L. Allen, M.D., Jonathan E. Kolitz, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 2833.

https://doi.org/10.1182/blood.V118.21.2833.2833

Published: 2011

Journal Articles

Differential Expression Genes of CLL Subgroups Defined by Ki67 Expression Level Which Correlated with Clinical Outcome

Xiao-Jie Yan, M.D., Ph.D., Daniel Kalenscher, Erin Boyle, Arrti Damle, Sophie Yancopoulos, Ph.D., Rajendra N Damle, PhD, Houman Khalili, Annette Lee, PhD, Wentian Li, Ph.D., Igor Dozmorov, MD, PhD, Matthew Kaufman, M.D., Peter Gregersen, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, M.D.

Blood (2010) 116 (21): 2435.

https://doi.org/10.1182/blood.V116.21.2435.2435

Published: 2010

Journal Articles

Expression Levels of a Single Gene, Lymphoid Enhancer Binding Factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies.

Brian A. McCarthy, PhD, Mike Tipping, Ph.D., Xue Ping Wang, Ph.D., Fiona Bennet, Ph.D., Wentian Li, Ph.D., Martin Lesser, Ph.D., Santanu Paul, Ph.D., Erin Boyle, B.S., Carol Moreno, Ph.D., Rosa Catera, Ph.D., Bradley T. Messmer, Ph.D., Steven L. Allen, M.D., Andrew C. Rawstron, M.D., Kanti R. Rai, M.D, Nicholas Chiorazzi, M.D.

Blood (2007) 110 (11): 1113.

https://doi.org/10.1182/blood.V110.11.1113.1113

Published: 2007

NARROW

A Systematic Search Into The Role Of IGHV Gene Replacement In Shaping The Immunoglobulin Repertoire Of Chronic Lymphocytic Leukemia

Apparent Involvement Of The Interferon, RNA Processing, and Wnt Signaling Pathways In Monoclonal B Lymphocytosis

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

Differential Expression Genes of CLL Subgroups Defined by Ki67 Expression Level Which Correlated with Clinical Outcome

Expression Levels of a Single Gene, Lymphoid Enhancer Binding Factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

A Systematic Search Into The Role Of IGHV Gene Replacement In Shaping The Immunoglobulin Repertoire Of Chronic Lymphocytic Leukemia

Apparent Involvement Of The Interferon, RNA Processing, and Wnt Signaling Pathways In Monoclonal B Lymphocytosis

Gene Expression Profiles Document That Recently- and Previously-Divided CLL Fractions Represent a Continuum but Suggest Differing Modes of Activation for These Fractions in U-CLL and M-CLL

Combining Expression of Hypervariably Expressed Genes with IGHV Mutation Status Is a More Robust Prognostic Indicator Than Mutation Status Alone in Chronic Lymphocytic Leukemia

Gene Set Enrichment Analysis of Ki-67 high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease

Differential Expression Genes of CLL Subgroups Defined by Ki67 Expression Level Which Correlated with Clinical Outcome

Expression Levels of a Single Gene, Lymphoid Enhancer Binding Factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only